Next Up, Parkinson's: Coalition Against Major Diseases Moves To Link Neurodegenerative Ailments In Database
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The Coalition Against Major Diseases will move to create a database of Parkinson's disease trials after unveiling a similar product for Alzheimer's disease
You may also be interested in...
Sounding The Alarm On The Future Of CNS Drug Development
The drug development paradigm for new central nervous system therapeutics is in need of a thorough reimagining, Tufts Center for the Study of Drug Development researchers assert in an analysis published in Scientific American.
Sounding The Alarm On The Future Of CNS Drug Development
The drug development paradigm for new central nervous system therapeutics is in need of a thorough reimagining, Tufts Center for the Study of Drug Development researchers assert in an analysis published in Scientific American.
Avandia Aftershocks: Will FDA Drug Safety Review Structures Crumble?
Rep. Rosa DeLauro's, D-Conn., hearing on the safety of GlaxoSmithKline's diabetes drug Avandia has ratcheted up the pressure on FDA to make broad reforms of its review structure, but the congresswoman has been careful not to urge a particular course of action for the agency
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: